Acroosteolysis
A condition involving bone resorption in the fingers and toes
Overview[edit | edit source]
Acroosteolysis is a medical condition characterized by the resorption of the distal phalanges of the fingers and toes. This condition can lead to the shortening of the digits and is often associated with various underlying disorders. Acroosteolysis can be identified through radiographic imaging, which reveals the loss of bone in the affected areas.
Causes[edit | edit source]
Acroosteolysis can be caused by a variety of factors, including:
- Genetic disorders such as Hajdu-Cheney syndrome and Progeria.
- Occupational exposure to polyvinyl chloride (PVC).
- Scleroderma, a connective tissue disease that can lead to skin thickening and bone resorption.
- Psoriatic arthritis, which can cause joint inflammation and bone changes.
- Hyperparathyroidism, where excessive parathyroid hormone leads to bone resorption.
Symptoms[edit | edit source]
The primary symptom of acroosteolysis is the shortening of the fingers and toes due to bone loss. Other symptoms may include:
- Pain in the affected digits.
- Swelling and tenderness.
- Deformity of the fingers and toes.
- Limited range of motion.
Diagnosis[edit | edit source]
Diagnosis of acroosteolysis is primarily based on X-ray findings, which show the characteristic bone resorption at the distal phalanges. Additional diagnostic tests may include:
- Blood tests to identify underlying metabolic or autoimmune conditions.
- Genetic testing for hereditary syndromes.
- Bone density scans to assess overall bone health.
Treatment[edit | edit source]
Treatment of acroosteolysis focuses on managing the underlying cause and alleviating symptoms. Options may include:
- Medications to treat underlying conditions such as autoimmune diseases or hormonal imbalances.
- Physical therapy to maintain mobility and function of the affected digits.
- Surgical intervention in severe cases to correct deformities or stabilize joints.
Prognosis[edit | edit source]
The prognosis for individuals with acroosteolysis varies depending on the underlying cause. Early diagnosis and treatment of the primary condition can improve outcomes and prevent further bone loss.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD